Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Prune belly syndrome is a rare congenital disorder, belonging to the group of fetal lower urinary tract obstructions (LUTO), involving variable dilation of the lower urinary tract in association with partial or complete absence of the lateral and inferior abdominal wall musculature and in males bilateral non-palpable undescended testes.
Features include always present findings: Congenital posterior urethral valve, Slow pupillary light response, and Xerostomia; and common findings: Prune belly. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Pregnancy and birth | 2 | Congenital hip dislocation, Congenital posterior urethral valve |
Digestive system | 1 | Aplasia of the abdominal wall musculature |
CHRM3 encodes cholinergic receptor muscarinic 3 (590 aa). The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Highest expression in Esophagus Muscularis (12.4 TPM) and Esophagus Gastroesophageal Junction (11.2 TPM).
Prune belly syndrome is associated with mutations in the CHRM3 gene on chromosome 1.
CHRM3 is classified as a druggable target (Druggable Genome and G Protein Coupled Receptor categories) with score 1.4.
Genetic testing for CHRM3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for prune belly syndrome has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 1 common feature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include procedural interventions. Research is primarily sponsored by academic and government institutions.
167 publications have been identified in PubMed for prune belly syndrome. Research spans Review / Meta-Analysis (54%), Case Report / Case Series (19%), and Basic Science / Preclinical (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 90 | 54% |
Patient case studies | 31 | 19% |
Laboratory research | 18 | 11% |
Disease patterns and progression | 14 | 8% |
Testing and diagnosis research | 5 | 3% |
Other research | 4 | 2% |
Clinical study results | 4 | 2% |
New treatment approaches | 1 | 1% |
Chu E (2026). [PMID: 41719823](https://pubmed.ncbi.nlm.nih.gov/41719823/). *J Pediatr Urol*. [Case Report / Case Series]
Nayak M (2026). [PMID: 41667200](https://pubmed.ncbi.nlm.nih.gov/41667200/). *BMJ Case Rep*. [Case Report / Case Series]
Sebode M (2026). [PMID: 41432137](https://pubmed.ncbi.nlm.nih.gov/41432137/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Avelino-Silva TJ (2026). [PMID: 41591773](https://pubmed.ncbi.nlm.nih.gov/41591773/). *JAMA Netw Open*. [Epidemiology / Natural History]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Braz Ascar PC (2026). [PMID: 42055902](https://pubmed.ncbi.nlm.nih.gov/42055902/). *J Pediatr Urol*. [Case Report / Case Series]
Sayyed Ahmad M (2026). [PMID: 41625586](https://pubmed.ncbi.nlm.nih.gov/41625586/). *Radiol Case Rep*. [Case Report / Case Series]
Sati DM (2026). [PMID: 42185115](https://pubmed.ncbi.nlm.nih.gov/42185115/). *J Pediatr Urol*. [Other]
Archambeaud A (2026). [PMID: 41056436](https://pubmed.ncbi.nlm.nih.gov/41056436/). *Rheumatology (Oxford)*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Diagnostic / Biomarker]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 4:30 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center